As clinical trials become increasingly complex and outsourced, sponsors must navigate a growing ecosystem of CROs, technology vendors, and specialist service providers. While outsourcing provides operational expertise and scalability, regulatory accountability always remains with the sponsor.

Sunrise Clinical examines common oversight gaps identified through regulatory inspections and explores how sponsors can move beyond passive CRO management toward active governance.